Meeting News

Low clinical value in repeat latent tuberculosis tests in patients taking biologics

November 14, 2019
Repeat, routine testing for latent tuberculosis infection among patients receiving biologics is both costly and of low clinical value, according to…

In the Journals

Xpert Ultra assay identifies pediatric TB with high sensitivity

October 30, 2019
An updated version of the Xpert Mycobacterium tuberculosis and rifampin assay, known as Ultra, demonstrated high sensitivity in diagnosing pulmonary…

World Lung Day 2019: A focus on universal health coverage

September 25, 2019
Today marks World Lung Day, and this year’s theme is “healthy lungs for all.” To raise awareness, medical societies, advocacy…

In the JournalsPerspective

TB rates declining among US children, but disparities persist

August 22, 2019
Although the rate of new tuberculosis cases among U.S. children and adolescents has decreased by nearly half in recent years, incidence of the…

FDA News

Pretomanid, first TB drug developed by non-profit, gets FDA approval for resistant infections

August 14, 2019
The FDA has approved pretomanid — the first tuberculosis drug developed by a non-profit organization — as part of a three-drug regimen…

In the Journals

Estimated global prevalence of latent TB about 25%

July 31, 2019
About one-quarter of the world’s population may be infected with latent tuberculosis, according to a systematic review and meta-analysis…

NIH launches delamanid trial for MDR-TB prevention

June 28, 2019
The National Institute of Allergy and Infectious Diseases, part of the NIH, has launched a trial investigating the safety and efficacy of delamanid…


Q&A: Time to retire tuberculin skin tests?

June 26, 2019
Two tests are currently available to assist with the diagnosis of tuberculosis: tuberculin skin tests, or TSTs, and an interferon-gamma release…

In the Journals

Occupational hazards may account for range of lung diseases

June 21, 2019
Occupational hazards, which include inhaling vapors, gas, dust or fumes at work, may be responsible for a number of noncancerous lung diseases…


1 million child-friendly TB courses ordered since 2016

June 17, 2019
Approximately 1 million treatment courses of new tuberculosis medicines designed for easy administration in children have been ordered by 93…

In the Journals

CDC expands treatment recommendation for latent TB to younger children

June 29, 2018
The CDC has expanded its recommendation of a short-course combination regimen of once-weekly isoniazid and rifapentine for the treatment of latent…

Meeting NewsVideo

VIDEO: Index patient in Minnesota MDR-TB outbreak was infectious for 5 years

April 21, 2018
ATLANTA — In this video from the CDC’s Epidemic Intelligence Service conference, Victoria Hall, DVM, MS, EIS officer in the Minnesota…

In the Journals PlusPerspective

Trained rats more successful in diagnosing TB than standard tests

April 14, 2018
African giant pouched rats that are trained to detect tuberculosis identified hundreds of cases that were missed by clinic-based testing in Tanzania…

In the Journals

Four-gene signature predicts TB progression

April 11, 2018
A genetic signature predicted the progression of tuberculosis in household contacts of active cases up to 2 years before disease onset, according to…

Improving social welfare could reduce most TB incidence worldwide

March 29, 2018
Researchers estimated that reaching WHO’s No. 1 Sustainable Development Goal of ending extreme poverty and expanding social protection could…

In the Journals

Daily therapy superior to intermittent for TB in patients with HIV

March 7, 2018
A daily antituberculosis regimen prevented rifampicin resistance and was more effective than an intermittent regimen among patients with HIV with…

Meeting News

Urine-based TB testing identifies additional cases

March 6, 2018
BOSTON — The addition of systematic urine screening to sputum screening identified more cases of tuberculosis and was associated with a 50%…

Meeting News

Higher rifampin doses safe for patients with pulmonary TB

March 6, 2018
BOSTON — Results of a phase 2 randomized clinical trial show that up to twice the standard daily dose of rifampin was safe in patients with…

Meeting NewsPerspective

1 month of TB prophylaxis as effective as 9 months

March 5, 2018
BOSTON — A 1-month antibiotic regimen to prevent active tuberculosis in patients living with HIV was just as effective and caused fewer adverse…


Xpert MTB/RIF Ultra: Another advance in TB diagnostics

Infectious Disease News, January 2018
David L Cohn, MD
The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of tuberculosis in decades. This…

Healio Jobs